Medicine, syringe samples found substandard or counterfeit in Sindh

A total of 79 samples of allopathic medicines, herbal products, and medical syringes have been declared substandard or counterfeit in Sindh, according to the latest report issued by the Sindh Drug Testing Laboratory. The findings have raised concerns over the quality of pharmaceutical products and medical supplies being used in healthcare facilities across the province.

The laboratory released the report after examining samples collected between January and July 13. According to the report, more than 2,000 samples of medicines and syringes were tested to assess whether they met the approved quality and safety standards. Out of these, 79 samples failed to comply with the required specifications, indicating that they were either of poor quality or counterfeit.

Among the products that failed the quality assessment were 30 samples of auto-disable (AD) syringes, which were found to be substandard or fake. Auto-disable syringes are specially designed for single use and automatically become unusable after one injection. They play a vital role in preventing the reuse of syringes and reducing the spread of infectious diseases.

The report warned that the use of low-quality or counterfeit syringes poses serious risks to public health. If a syringe is reused on multiple patients, it significantly increases the likelihood of transmitting infections through contaminated blood. Such practices can also compromise the effectiveness of medical treatment and expose patients to avoidable health complications.

Health experts have long emphasized that the use of certified, high-quality auto-disable syringes is one of the most effective ways to prevent the transmission of blood-borne diseases. The report reiterated that ensuring the availability of standard-compliant AD syringes can help reduce the spread of infections such as HIV, hepatitis B, hepatitis C, and other diseases transmitted through unsafe injection practices.

The laboratory recommended that only approved and quality-tested medical products be supplied to hospitals, clinics, and pharmacies. It also stressed the need for stronger regulatory oversight, regular inspections, and strict enforcement against the manufacture, distribution, and sale of counterfeit or substandard medicines and medical equipment.

The findings underscore the importance of maintaining rigorous quality control within Pakistan’s pharmaceutical supply chain. Public health officials have repeatedly warned that counterfeit medicines and fake medical devices not only threaten patient safety but also undermine confidence in the healthcare system.

The report serves as a reminder for healthcare providers to purchase medicines and medical supplies only from licensed and authorized distributors. Patients are also encouraged to remain vigilant and seek medical treatment from reputable healthcare facilities where approved medical products are used.

Authorities are expected to investigate the manufacturers and suppliers responsible for the failed samples and take legal action where necessary. Strengthening monitoring mechanisms and improving quality assurance procedures will be essential to preventing similar cases in the future.

The latest findings highlight the need for continued efforts to safeguard public health by ensuring that medicines and medical equipment available in the market meet the highest safety and quality standards. Experts believe that stricter regulation, enhanced testing, and increased public awareness will play a key role in protecting patients and preventing the spread of infectious diseases linked to unsafe medical practices.